Eventide Asset Management »

Axsome Therapeutics shares owned by Eventide Asset Management

Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Eventide Asset Management from 13F filings

Historical chart of Eventide Asset Management investment in Axsome Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Axsome Therapeutics held by Eventide Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axsome Therapeutics by Eventide Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $28M 347k 79.59
2023-09-30 $24M 347k 69.89

More positions owned by Eventide Asset Management

Xometry Class A Com (XMTR)
Trane Technologies SHS (TT)
Zentalis Pharmaceuticals (ZNTL)
Old Dominion Freight Line (ODFL)
Celldex Therapeutics Com New (CLDX)
Roper Industries (ROP)
Crowdstrike Hldgs Cl A (CRWD)
IDEXX Laboratories (IDXX)
Palo Alto Networks (PANW)
Waste Connections (WCN)
D.R. Horton (DHI)
Pool Corporation (POOL)
Guardant Health (GH)
Global E Online SHS (GLBE)
Flywire Corporation Com Vtg (FLYW)

View all positions for Eventide Asset Management

Top funds holding Axsome Therapeutics

Vanguard Group
Fairmount Funds Management
BVF
Citadel Advisors
Perceptive Advisors
RA Capital Management
Millennium Management
Point72 Asset Management
Alethea Capital Management
Bellevue Group
Partner Fund Management
Avidity Partners Management
Boxer Capital
Eventide Asset Management
Tang Capital Management

View all funds holding Axsome Therapeutics